| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 2293 | 2014 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 810 | 2016 |
| Pure alexia as a disconnection syndrome: new diffusion imaging evidence for an old concept S Epelbaum, P Pinel, R Gaillard, C Delmaire, M Perrin, S Dupont, ... Cortex 44 (8), 962-974, 2008 | 272 | 2008 |
| APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: A genetic screening study of familial and sporadic cases HM Lanoiselée, G Nicolas, D Wallon, A Rovelet-Lecrux, M Lacour, ... PLoS medicine 14 (3), e1002270, 2017 | 175 | 2017 |
| Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World … P Lewczuk, P Riederer, SE O’Bryant, MM Verbeek, B Dubois, PJ Visser, ... The world journal of biological psychiatry 19 (4), 244-328, 2018 | 121 | 2018 |
| Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020 H Hampel, S Lista, SJ Teipel, F Garaci, R Nisticò, K Blennow, ... Biochemical pharmacology 88 (4), 426-449, 2014 | 111 | 2014 |
| Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study B Dubois, S Epelbaum, F Nyasse, H Bakardjian, G Gagliardi, ... The Lancet Neurology 17 (4), 335-346, 2018 | 107 | 2018 |
| Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia RER Slot, SAM Sikkes, J Berkhof, H Brodaty, R Buckley, E Cavedo, ... Alzheimer's & Dementia 15 (3), 465-476, 2019 | 94 | 2019 |
| Detection of volume loss in hippocampal layers in Alzheimer's disease using 7 T MRI: a feasibility study C Boutet, M Chupin, S Lehéricy, L Marrakchi-Kacem, S Epelbaum, ... NeuroImage: Clinical 5, 341-348, 2014 | 79 | 2014 |
| Alzheimer's disease biomarker‐guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: Aβ1–42, total‐tau … H Hampel, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 14 (4), 492-501, 2018 | 62 | 2018 |
| Preclinical Alzheimer's disease: a systematic review of the cohorts underlying the concept S Epelbaum, R Genthon, E Cavedo, MO Habert, F Lamari, G Gagliardi, ... Alzheimer's & Dementia 13 (4), 454-467, 2017 | 53 | 2017 |
| Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease A Vergallo, L Mégret, S Lista, E Cavedo, H Zetterberg, K Blennow, ... Alzheimer's & Dementia 15 (6), 764-775, 2019 | 51 | 2019 |
| Symptomatic and proven de novo amyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients D Adams, C Lacroix, T Antonini, P Lozeron, C Denier, AM Kreib, ... Amyloid 18 (sup1), 174-177, 2011 | 42 | 2011 |
| Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease S Lista, N Toschi, F Baldacci, H Zetterberg, K Blennow, I Kilimann, ... Neurochemistry international 108, 355-360, 2017 | 41 | 2017 |
| Two‐level diagnostic classification using cerebrospinal fluid YKL‐40 in Alzheimer's disease F Baldacci, N Toschi, S Lista, H Zetterberg, K Blennow, I Kilimann, ... Alzheimer's & Dementia 13 (9), 993-1003, 2017 | 39 | 2017 |
| 17q21. 31 duplication causes prominent tau-related dementia with increased MAPT expression K Le Guennec, O Quenez, G Nicolas, D Wallon, S Rousseau, AC Richard, ... Molecular psychiatry 22 (8), 1119-1125, 2017 | 38 | 2017 |
| Free and Cued Selective Reminding Test–accuracy for the differential diagnosis of Alzheimer's and neurodegenerative diseases: a large-scale biomarker-characterized monocenter … M Teichmann, S Epelbaum, D Samri, ML Nogueira, A Michon, H Hampel, ... Alzheimer's & Dementia 13 (8), 913-923, 2017 | 37 | 2017 |
| Verbal memory impairment in subcortical ischemic vascular disease: a descriptive analysis in CADASIL S Epelbaum, S Benisty, S Reyes, M O'Sullivan, E Jouvent, M Düring, ... Neurobiology of aging 32 (12), 2172-2182, 2011 | 37 | 2011 |
| Sex differences in functional and molecular neuroimaging biomarkers of Alzheimer's disease in cognitively normal older adults with subjective memory complaints E Cavedo, PA Chiesa, M Houot, MT Ferretti, MJ Grothe, SJ Teipel, S Lista, ... Alzheimer's & Dementia 14 (9), 1204-1215, 2018 | 36 | 2018 |
| Added value of 18F‐florbetaben amyloid PET in the diagnostic workup of most complex patients with dementia in France: A naturalistic study M Ceccaldi, T Jonveaux, A Verger, P Krolak‐Salmon, C Houzard, ... Alzheimer's & Dementia 14 (3), 293-305, 2018 | 35 | 2018 |
